Duncan Barbara Gayle
CIK 0001353128
Director
Filings
22
Latest May 7, 2026
Issuers covered
5
Showing
22 of 22
Page 1
Track record
Realized signed returns on open-market buys and sales
No scored trades yet for Duncan Barbara Gayle. Track record appears once open-market purchases or sales reach the +30 day horizon.
Issuers
Companies where Duncan Barbara Gayle has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| OVID | Ovid Therapeutics Inc. | 7 | Mar 2, 2026 |
| AVIR | Atea Pharmaceuticals, Inc. | 5 | Jun 24, 2025 |
| HALO | Halozyme Therapeutics, Inc. | 5 | May 7, 2026 |
| FUSN | Fusion Pharmaceuticals Inc. | 3 | Jun 4, 2024 |
| JNCE | Jounce Therapeutics, Inc. | 2 | May 4, 2023 |
All filings
22 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|